The primary aim was to compare concentrations of psychoactive substances in blood in non-fatal and fatal opioid overdoses. The secondary aim was to assess the concentration levels of naloxone in blood in non-fatal overdoses and the association between naloxone findings and concomitantly detected drugs. To read the full article, log in using your NHS OpenAthens details.
The World Health Organization's (WHO's) proposed International Classification of Diseases, 11th Edition (ICD‐11) includes several major revisions to substance use disorder (SUD) diagnoses. It is essential to ensure the consistency of within‐subject diagnostic findings across countries, languages and cultures. To date, agreement analyses between different SUD diagnostic systems have largely been based in high‐income countries and clinical samples rather than general population samples. We aimed to evaluate the prevalence of, and concordance between diagnoses using the ICD‐11, The WHO's ICD 10th Edition (ICD‐10), and the Diagnostic and Statistical Manual of Mental Disorders, 4th and 5th editions (DSM‐IV, DSM‐5); prevalence of disaggregated ICD‐10 and ICD‐11 symptoms; and variation in clinical features across diagnostic groups.. Please contact the library to request a copy of this article - http://bit.ly/1Xyazai
Adolescents who regularly use marijuana may be at heightened risk of developing subclinical and clinical psychotic symptoms. However, this association could be explained by reverse causation or other factors. To address these limitations, the current study examined whether adolescents who engage in regular marijuana use exhibit a systematic increase in subclinical psychotic symptoms that persists during periods of sustained abstinence. Login at top right hand side of page using your SSSFT NHS Athens for full text. SSOTP - request a copy of the article from the library http://bit.ly/1Xyazai
Canadian Psychology/Psychologie canadienne58.1 (Feb 2017): 50-57.
People with concurrent disorders (CDs; i.e., mental illness and substance use disorders) are at high risk for a number of adverse outcomes if they do not receive appropriate treatment. Yet despite wide availability of evidence-based guidelines and easy-to-access clinical resources for this population, implementation has lagged. Integrated treatment involves targeting both the substance use and the mental illness at the same time in a systematic way and is a recommended practice for CDs. However, very little true integration of addiction and mental health services has occurred in Canada. This review outlines the main best-practice guidelines for working with people with CDs and describes some of the barriers and facilitators to integration. An example of successful integrated treatment is presented, with suggestions for how psychologists can play a key role in this important work. (PsycINFO Database Record (c) 2017 APA, all rights reserved) (Source: journal abstract) To read the full article, log in using your NHS OpenAthens details.
Journal of Consulting and Clinical Psychology85.9 (Sep 2017): 862-872.
Background: Prevalence of smoking among individuals with posttraumatic stress disorder (PTSD) is disproportionately high, and PTSD is associated with especially poor response to smoking cessation treatment. Objective: The current study examined whether integrating treatments for smoking cessation (varenicline plus smoking cessation counseling; VARCC) and PTSD (prolonged exposure therapy; PE) enhances smoking outcomes among smokers diagnosed with PTSD. To read the full article, log in using your NHS OpenAthens details.
To identify the distinguishing characteristics of alcohol dependent patients who confuse alcohol cravings with pre-meal hunger. To read the full article, choose Open Athens “Institutional Login” and search for “Midlands Partnership”.
Psychology of Addictive Behaviors Vol. 31, Iss. 8, (Dec 2017): 897-906.
Contingency management (CM) interventions consistently improve substance abuse treatment outcomes, yet CM remains a highly controversial intervention and is rarely implemented in practice settings. This article briefly outlines the evidence base of CM and then describes 4 of the most often-cited concerns about it: philosophical, motivational, durability, and economic.. To read the full article, log in using your NHS OpenAthens details.
This toolkit is for services which provide substance misuse treatment in prisons, other secure settings, and the community.
It is aimed at both the providers and commissioners of these services.
The toolkit can be used to support people with substance misuse treatment needs who are leaving prison.
It includes:
guidance on how to improve continuity of care
Neither the predictive value of early continuous abstinence in alcohol use disorder (AUD) or the point at which this effect may emerge has been evaluated. This analysis of the Combined Pharmacotherapies and Behavioral Interventions (COMBINE) clinical trial evaluated whether abstinence early in treatment was a predictor of longer term abstinence. Please contact the library to request a copy of this article - http://bit.ly/1Xyazai
Neither the predictive value of early continuous abstinence in alcohol use disorder (AUD) or the point at which this effect may emerge has been evaluated. This analysis of the Combined Pharmacotherapies and Behavioral Interventions (COMBINE) clinical trial evaluated whether abstinence early in treatment was a predictor of longer term abstinence. Please contact the library to request a copy of this article - http://bit.ly/1Xyazai
There is inconsistent evidence that alcohol-specific coping is a mechanism of change in cognitive-behavioral therapy (CBT) for alcohol use disorder (AUD). Our primary aim was to test whether baseline dependence severity moderates the mediational effect of CBT on drinking outcomes via coping. Please contact the library to request a copy of this article - http://bit.ly/1Xyazai
Risky single occasion drinking (RSOD) by young people is a serious public health issue, yet little is known about the specific circumstances of risky drinking occasions. This study examined the independent effects of event- and individual-specific variables on RSOD. Please contact the library to request a copy of this article - http://bit.ly/1Xyazai
Psychological Trauma: Theory, Research, Practice, and Policy8.1 (Jan 2016): 41-48.
Substantial rates of substance use comorbidity have been observed among veterans with Post-Traumatic Stress Disorder (PTSD), highlighting the need to identify patient and program characteristics associated with improved outcomes for substance abuse. To read the full article, log in using your NHS OpenAthens details
In a recent randomized trial, patients with opioid dependence receiving brief intervention, emergency department (ED)-initiated buprenorphine and ongoing follow-up in primary care with buprenorphine (buprenorphine) were twice as likely to be engaged in addiction treatment compared with referral to community-based treatment (referral) or brief intervention and referral (brief intervention). Our aim was to evaluate the relative cost-effectiveness of these three methods of intervening on opioid dependence in the ED. Please contact the library to request a copy of this article - http://bit.ly/1Xyazai
Criminal-justice-involved persons are highly susceptible to opioid relapse and overdose-related deaths. In a recent randomized trial, we demonstrated the effectiveness of extended release naltrexone (XR-NTX; Vivitrol®) in preventing opioid relapse among criminal-justice-involved U.S. adults with a history of opioid use disorder. The cost of XR-NTX may be a significant barrier to adoption. Thus, it is important to account for improved quality of life, and downstream cost-offsets. Our aims were to (1) estimate the incremental cost per quality-adjusted life-year (QALY) gained for XR-NTX versus treatment as usual (TAU), and evaluate it relative to generally-accepted value thresholds; and (2) estimate the incremental cost per additional year of opioid abstinence. Please contact the library to request a copy of this article - http://bit.ly/1Xyazai
The article by Laramée et al. (2016) concerning ‘the cost-effectiveness of the integration of nalmefene for alcohol dependence’ deserves careful attention because it is one of the few and very similar decision-modelling studies available supporting nalmefene use for harm reduction among people treated for alcohol dependency. But can results derived from models replace evidence?
Indeed, the nalmefene Phase 3 programme was controversial. When the whole body of evidence derived from randomised controlled trials (RCTs) is considered, a meta-analysis (Palpacuer et al., 2015) found that ‘the value of nalmefene for treatment of alcohol addiction is not established’ and that ‘nalmefene has limited efficacy in reducing alcohol consumption’. In addition, an attrition bias could not be excluded in these studies, with more withdrawals for nalmefene than for placebo, including more withdrawals for safety reasons. Please contact the library to request a copy of this article - http://bit.ly/1Xyazai
To determine the cost‐effectiveness of electronic‐ and clinician‐delivered SBIRT (Screening, Brief Intervention and Referral to Treatment) for reducing primary substance use among women treated in reproductive health centers.. To read the full article, log in using your NHS Athens details. To access full-text: click “Log in/Register” (top right hand side). Click ‘Institutional Login’ then select 'OpenAthens Federation', then ‘NHS England’. Enter your Athens details to view the article.